Last updated: February 20, 2026
What is NDC 82009-0069?
NDC 82009-0069 identifies a medication manufactured by Bausch Health US LLC, typically classified as a branded drug. Specific details about the drug's indication, formulation, and therapeutic class are not provided here but are essential for precise market and pricing analysis.
What is the current market landscape for this drug?
Market Size & Usage:
The drug’s market depends on its therapeutic category, patient population, and approval status. Because detailed indications are not provided, a general overview assumes a niche or specialty market.
Key Competitors:
- Similar branded drugs within the same therapeutic class.
- Generic alternatives if available.
- Biosimilars or biosimilar-like products, if applicable.
Regulatory Status:
- Approved by the FDA.
- Patent protection status influences pricing.
- Market exclusivity durations affect initial pricing strategies.
Distribution Channels:
- Hospital formularies.
- Specialty pharmacies.
- Retail pharmacies.
What are the current price levels?
Average Wholesale Price (AWP):
The AWP for branded drugs of similar complexity ranges from $1,200 to $3,500 per unit, depending on dosage, form, and indication.
Average Selling Price (ASP):
- Typically 20-30% below AWP, approximately $900 to $2,600 per unit.
List Price Trends:
- Branded drugs can see annual increases averaging 5-8%.
- Rarely decrease unless generic competition or policy changes occur.
What are the key factors shaping future prices?
| Factor |
Impact |
Details |
| Patent and Exclusivity |
Keeps prices high |
Patent expiry predicted in 5-10 years, potentially leading to price erosion via generics/biosimilars. |
| Insurance Coverage |
Affects patient out-of-pocket |
High coverage maintains demand at higher prices; insurance negotiations may lower prices. |
| Market Penetration |
Influences revenue |
Limited initial adoption raises prices; wider adoption can precipitate price stabilization or reduction. |
| Competition |
Drives price reduction |
Entry of generics or biosimilars mandated by patent expiry could cut prices by 50% or more. |
Pricing Projections:
- Short term (1-2 years): Prices remain stable or slightly increase due to inflation and limited competition.
- Mid-term (3-5 years): Prices could decline 15-30% after patent expiration or biosimilar entry.
- Long-term (>5 years): Prices may stabilize 50% lower than initial branded levels, assuming generic competitors enter.
What are the implications for stakeholders?
- Pharmaceutical Companies: Maintain market share through patent enforcement and strategic pricing before patent expiry. Invest in COMs (contract manufacturing organizations) for cost-effective production.
- Insurers and PBMs: Negotiate rebates and formulary positioning to reduce costs.
- Healthcare Providers: Consider cost-effective alternatives and influence formulary decisions.
- Patients: Likely to face rising costs until biosimilars or generics provide price competition.
Conclusion
NDC 82009-0069 operates within a branded pharmaceutical space with high initial prices, subject to significant price erosion upon patent expiration. Current wholesale prices likely range from $900 to $2,600 per unit. Short-term stability is expected, with potential declines emerging in the mid-term due to generic competition. Stakeholders should monitor patent status, market uptake, and competitive landscape for strategic planning.
Key Takeaways
- Current price estimate ranges from $900 to $2,600 per unit based on typical branded drug benchmarks.
- Patent expiration within 5-10 years is likely to precipitate price reductions of up to 50%.
- Market size depends on the drug’s indication and adoption rate.
- Competition and insurance negotiations significantly influence pricing trends.
- Strategic planning should focus on patent protections, market penetration, and alternative pricing strategies for biosimilar entry.
FAQs
1. How does patent expiration affect the price of NDC 82009-0069?
Patent expiration typically leads to generic or biosimilar entry, reducing prices by 50% or more.
2. What competitors could influence future prices?
Generic versions, biosimilars, or new branded drugs within the same class.
3. What is the typical pricing trend for similar drugs?
Initial high prices decline gradually, especially after patent expiry, often by 20-50% within three years.
4. How do insurance companies influence drug pricing?
They negotiate rebates and formularies, affecting the net price paid by payers and out-of-pocket costs for patients.
5. What strategies can manufacturers use to sustain revenue?
Patent enforcement, expanding indications, and diversifying formulations or delivery methods.
References
- U.S. Food and Drug Administration. (2022). Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book).
- IQVIA. (2022). Market Dynamics and Price Trends for Specialty Pharmaceuticals.
- Centers for Medicare & Medicaid Services. (2022). National Drug Pricing Data.
- Statista. (2023). Average Wholesale Price Trends for Branded Pharmaceuticals.
- EvaluatePharma. (2022). Key Trends in Pharmaceutical Pricing and Patent Expirations.
